New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2014
09:39 EDTWSTAmgen likely plans to use West's SmartDose, says CL King
CL King says a recent investor presentation from Amgen (AMGN) reviewing evolocumab showed a drug administration device that looks identical to West Pharmaceutical's (WST) SmartDose. As such, the firm has a "very high level of confidence" that Amgen will be using West's SmartDose as one of the administration systems for its PCSK9 inhibitor evolocumab. CL King views the development as a "significant positive" for West and reiterates a Strong Buy rating on the stock with a $58 price target. Shares of West Pharmaceutical are up 3% to $45.56 in early trading.
News For WST From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 19, 2015
07:08 EDTWSTWest Pharmaceutical sees FY15 adjusted EPS $1.74-$1.92, consensus $1.97
Subscribe for More Information
07:07 EDTWSTWest Pharmaceutical reports Q4 adjusted EPS 45c, consensus 46c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use